Table 2.

EORTC QLQ C-30, FACT-G and MOSSSS scores throughout the duration of the study.

Questionnaire	Event Identifier	N	N *	Mean	Standard Deviation	Median	Min	Max	p-Value Compared with Baseline Score)
EORTC QLQ C-30	BASELINE	92	87	75.3	14.4	77.2	42.5	96.9	-
	VISIT1	87	61	74.6	13.7	77.8	37.5	95.0	0.563
	VISIT2	61	34	78.9	13.6	80.1	43.1	97.5	0.593
	VISIT3	34	23	78.1	16.5	83.6	38.3	97.5	0.191
	VISIT4	26	13	79.7	11.6	80.6	53.3	96.1	0.654
FACT-G	BASELINE	92	86	73.7	14.2	75.0	28.7	94.4	-
	VISIT1	87	61	74.8	13.4	75.9	31.5	94.2	0.166
	VISIT2	61	34	75.3	14.9	74.9	29.6	98.1	0.293
	VISIT3	34	23	79.6	13.9	77.9	50.0	99.0	0.094
	VISIT4	26	13	78.8	10.9	82.7	60.2	98.1	0.420
MOSSSS	BASELINE	92	86	87.0	17.0	93.4	19.7	100	-
	VISIT1	87	60	85.8	19.2	97.4	19.7	100	0.878
	VISIT2	61	34	89.9	15.5	96.7	22.4	100	0.073
	VISIT3	34	23	90.8	11.7	97.4	59.2	100	0.041
	VISIT4	26	13	90.8	13.4	96.1	56.6	100	0.440

N: Number of total patients for each cycle. N *: number of patients who adequately filled out the questionnaires. FACT-G: Functional Assessment of Cancer Therapy-General Score. EORTC: European Organization for Research and Treatment of Cancer QLQ-C30 Score. MOSSSS: Medical Outcomes Study Social Support Survey Score.